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INTRODUCTION
anemia (34%), leucocytopenia (5.8%) and thrombocytopenia (3.3%). [1] [2] [3] The mechanisms The myelodysplastic syndrome is a clonal invoked for these single lineage abnormalities were hemopoietic disorder characterized by an abnormal related to the decreased circulating time for some marrow proliferation that merges into acute and to the autoimmune reaction for others. myelogenous leukemia. It may be associated with Pancytopenia has been rarely reported. All cases prior cytotoxic treatment and recognized as a late were totally reversible as the antithyroid hormonal complication of chemotherapy particularly with treatment proceeded. The presence of a alkylating agent (t-MDS). It may also be secondary to myelodysplastic syndrome has not yet been clearly vitamin deficiency or acute toxicity and then it is often reversible. [1, 2] In the myelodysplastic syndrome, anemia is present in over 85% of patients with increased mean corpuscular volume (MCV), neutropenia is present in about 50% of the patients with frequently increased monocytosis, thrombocytopenia is present in 25% of the patients, the marrow cellularity is usually normal or increased, the proerythroblasts may be in excess with pathologic sideroblasts, a granulocytic hyperplasia is frequent, megakaryocytes are present and an increase in reticulin and collagen fibers of varying degree is common.
Untreated hyperthyroidism can be associated with described as a possible consequence of hyperthyroidism.
The observation of a new case of pancytopenia revealing a myelodysplastic syndrome in a patient with hyperthyroidism, which completely resolved under medical treatment led us to review the literature. In gathering information for this article, palpitations, pallor, low grade fever (38° -38.5°C), fine tremor Because of the unavailability of a cytogenetic laboratory, no and excessive perspiration. She had no evidence of focal or further karyotypic analysis was performed in this case to look general infection. She was noted to have an enlarged neck for 5q and/or 7q deletion seen in approximately 80% of toxic with a very large multinodular goiter. Complete work-up myelodysplastic syndromes and toxic acute myelogenous including isotopic bone scan, lumbar and dorsal CT scan and leukemias (t-MDS / t-AML). The patient denied ingesting any routine X-rays showed only severe osteopenia. CT scan of the toxic drugs and she never received any cytotoxic chemotherapy neck, the thorax and the abdomen showed a huge multinodular or radiotherapy. goiter extending into the retrosternal area. The electrocardiogram showed a supraventricular tachyarrythmia.
The reversible myelodysplastic syndrome has been described [4] Thyroid function tests revealed a TSH level of 0.02 mIU/l (N: separately from the hematological picture of hyperthyroidism. 0.25-4) and an fT3 level of 18 pmol/l (N: 4-10). The diagnosis of Reversible pancytopenia has been described after successful toxic multinodular goiter was made.
treatment of hyperthyroidism [ Table 1 ]. [5, 6, [9] [10] [11] [12] Thyroid hormones have been known to potentiate erythropoiesis via the ß-A blood count at diagnosis showed the white blood cells at adrenergic receptors and reduce the life-span of whole blood 2500 /ul and the platelets at 58.000/ul. The hemoglobin level component. [5] Immunological mechanisms have also been was 6.5 g/dl, the MCV was 88 fl. The sedimentation rate ESR suggested to be involved in the reduction of the life-span of blood cells and platelets. [5] To explain the pancytopenia, a bone marrow aspiration and biopsy The toxicity of thyroid hormones on bone marrow stem cells were performed: a moderately hypercellular marrow with may be direct or mediated by proteic inhibitory or growth moderate myelofibrosis and arrested hematopoiesis was noted.
factors. Although the ESR was accelerated suggesting an inflammatory process, all the routine immunologic tests were The patient was started on an antithyroid agent, carbimazole:
negative and after normalization of the blood picture it remains 30 mg tid. A marked improvement in the clinical picture was accelerated at >60 mm/h. seen within one month and the thyroid function returned to normal. The peripheral blood counts became normal one month Shaw and Mehta [6] suggest that thyroid hormones may have a later and the bone marrow analysis performed four months direct effect on hematopoiesis at a stage earlier than was 115 mm/h. later showed normal hematopoiesis with no evidence of myelodysplasia [ Figures 1 and 2] . A persistent response was observed six months later under medical treatment. The patient refused surgical treatment.
DISCUSSION
The fortuitous detection of a pancytopenic myelodysplasia in this 65-year-old lady with thyrotoxicosis led us to consider these two coexisting diseases as two separate entities that are not uncommon at this age group. The unexpected normalization of the hematological disorders under only anti-thyroid hormonal treatment is an uncommon event since the natural history of almost all primary myelodysplastic syndromes is to progress into acute myelogenous leukemia. [1, 2] erythropoietic stem cell differentiation, disturbing maturation and differentiation of the pluripotent stem cells. Granulopoiesis abnormalities and leukemia have also been described in association with hyperthyroidism and attributed to the direct toxicity of the thyroid hormones. [7, 8] In conclusion: Reversible myelodysplastic syndrome may be part of the blood picture changes seen in hyperthyroidism, probably due to direct toxic mechanism. ) .
